Navigation Links
Pearl Therapeutics Highlights Its Porous Particle Cosuspension Platform, Demonstrating Universal Applicability Across Multiple Drug Classes and Combination Products
Date:5/5/2011

of Pearl's cosuspension platform that allows MDIs – currently used to deliver over 70% of the inhaled doses worldwide – to be developed with long-acting muscarinic antagonists (LAMA), long-acting beta-2 adrenergic receptor agonists (LABA) and inhaled corticosteroids (ICS), in their natural crystalline form.  The evidence showed that the porous particles are practically insoluble in hydrofluoroalkane (HFA) propellant, and associate with micronized drug crystals in a way that reduces the interaction between crystals and with the inhaler components.  

A supporting poster provided a comparison of dual and triple cosuspensions of the potent LAMA, glycopyrrolate with either the highly potent LABA, formoterol fumarate, or the ICS, mometasone furoate, or both formoterol fumarate and mometasone furoate.  Pearl's porous particle cosuspensions, whether formed with one, two or three of these drugs, generate highly efficient aerosols with equivalent aerodynamic particle size distribution. Moreover, they maintain long-term chemical stability within internationally accepted limits for each drug after months of storage at room temperature, confirming the continuity of product performance across various product types with Pearl's cosuspension platform over time.  

Additionally, Pearl presented evidence that the cosuspensions form quickly and can be manufactured by pressure filling into MDIs using commercially available filling equipment and standard MDI components. Various doses of single, dual and triple combination cosuspensions were produced at small scale with a process representative of commercial scale, and were found to be stable with dose-proportional and uniform aerodynamic size distribution profiles.

Dr. Dwivedi added, "The Pearl cosuspension offers consistently efficient drug delivery across drug classes, doses and product types; no detrimental physical or chemical interaction between drugs or between drugs and inhale
'/>"/>

SOURCE Pearl Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Asante Solutions, Inc. Receives CE Mark for Pearl™ Insulin Pump
2. Pearl Therapeutics to Present Complete PT003 Results from Phase 2b COPD Study in a Late-Breaker Session at the American Thoracic Society Annual Meeting
3. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
6. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
7. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
8. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
11. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... percent of Americans believe the abuse of strong prescription pain ... safety issue in the United States , ... & Partners, a Cincinnati based research ... the prescription medication abuse problem and the need for medical ... facing our country," Rex Repass , CEO of the ...
(Date:8/21/2014)... 21, 2014 InfinityQS International, Inc., the ... Intelligence , today announces Infusion Chicago, its 9 ... be held Oct. 9-10, 2014, at the Chicago ... showcase the necessity for implementing a quality system ... Intelligence to gain insight into production processes. Complimentary ...
(Date:8/21/2014)... -- Professional Compounding Centers of America (PCCA) will ... three best scientific presentations at the sixth ... Formulating Better Medicines for Children  conference, held ... Greece , includes dozens of poster-style scientific ... three winners will be selected by a panel ...
Breaking Medicine Technology:Consumers Desperate For Measures To Curb Prescription Drug Abuse 2Consumers Desperate For Measures To Curb Prescription Drug Abuse 3InfinityQS to Host Manufacturing Intelligence Conference in Chicago 2Professional Compounding Centers of America will award top poster-session winners at European Paediatric Formulation Initiative in Athens 2
... Food and Drug Administration today allowed marketing of the first ... dengue fever or dengue hemorrhagic fever, a leading cause of ... (Logo:   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) The dengue ... infected Aedes mosquito. As many as 100 million ...
... 2011 The U.S. Food and Drug Administration today cleared ... assay that is designed to rapidly detect the toxin B ... cause of diarrhea that can lead to colitis, other serious ... http://photos.prnewswire.com/prnh/20090824/FDALOGO ) Clostridium difficile ( ...
Cached Medicine Technology:FDA Permits Marketing of First Test to Help Diagnose Dengue Fever 2FDA Permits Marketing of First Test to Help Diagnose Dengue Fever 3FDA Clears Test for Bacteria That Can Cause Serious Intestinal Disease 2
(Date:8/21/2014)... Hunhu Healthcare, Inc. , a Minneapolis-based ... it has entered into a licensing agreement with Mayo ... predictive analytics for recruiting, leveraging and managing its solution ... Michael Emerson , co-founder and CEO of Hunhu Healthcare, ... technology used in what he calls a social wellness ...
(Date:8/21/2014)... 2014 Quantum Innovations, Inc . ... to announce the healthcare technology platform, PWeR® 2.0 ... , The company anticipates provisioning its first provider over ... individual physicians, via interfaces, to medical laboratory, pharmacy, secure ... electronic data exchanges and medical clearing houses. , ...
(Date:8/21/2014)... According to new market research report, “Lactic ... Beverage, Personal care & Pharmaceutical) & Polylactic acid ... & Geography - Global Trends & Forecasts to ... markets and segments with analyses and projections of ... sub-segments, in terms of value and volume. It ...
(Date:8/21/2014)... 2014 Being overweight or obese may ... Although there is no cure, patients have learned ... lifestyle changes, such as losing excess weight and following ... is a joint disorder which causes discomfort and pain ... and can significantly reduce one’s quality of life. Although ...
(Date:8/21/2014)... Louis, MO (PRWEB) August 21, 2014 ... wellness in all aspects of life, St. Louis’ Sound ... for the better and revolutionized its online presence. Reorganized ... Mind Café, the new website makes navigating for information ... blue and an easily accessible menu-bar in jet black, ...
Breaking Medicine News(10 mins):Health News:Hunhu Healthcare Enters into Licensing Agreement with Mayo Clinic 2Health News:Grace Century’s Electronic Health Records Project, Quantum Innovations, Announces That PWeR® Healthcare Technology Platform is Ready for Deployment 2Health News:Grace Century’s Electronic Health Records Project, Quantum Innovations, Announces That PWeR® Healthcare Technology Platform is Ready for Deployment 3Health News:Grace Century’s Electronic Health Records Project, Quantum Innovations, Announces That PWeR® Healthcare Technology Platform is Ready for Deployment 4Health News:Lactic Acid Market Worth $3,577.5 Million & Polylactic Acid Market Worth $4,840.1 Million by 2019 – New Report 2Health News:Lactic Acid Market Worth $3,577.5 Million & Polylactic Acid Market Worth $4,840.1 Million by 2019 – New Report 3Health News:Diet Doc’s Medical Weight Loss Programs Announces Safe and Fast Weight Loss That Teach Patients How to Relieve Osteoarthritis Pain 2Health News:Diet Doc’s Medical Weight Loss Programs Announces Safe and Fast Weight Loss That Teach Patients How to Relieve Osteoarthritis Pain 3Health News:Sound Mind Cafe Launches Revamped Website and Hires Hypnotist to Team 2
... researchers say , FRIDAY, April 9 (HealthDay News) -- Children ... vaccines contained both strains of influenza B instead of just ... a second influenza B virus strain to the seasonal influenza ... selection and help improve the vaccine,s ability to prevent influenza," ...
... The commitment to health by country governments in the developing ... to a new study by the Institute for Health Metrics ... Medical School. Overall domestic government spending on health ... billion in 2006, the study shows. That is three times ...
... , ... developer for his own use, this hand polished and sculpted mouse pad is now available ... functional addition to any desktop. , ... (PRWEB) April 9, 2010 -- Dxtra Announces the availability of the world,s only solid ...
... should be paid to prevention and treatment, expert says ... can create serious problems for smokers who have a ... to a new study. , Researchers from Caen University ... nicotine withdrawal can become highly agitated and accidentally remove ...
... ... raise awareness of violence and abuse , ... Washington, D.C. (Vocus) April 9, 2010 -- Children,s National Medical Center,s Teen Life ... artwork designed by youth who have been affected by violence or abuse. , , , ...
... social security fund on a global scale. That is what ... in a Viewpoint in the leading medical journal The ... the use of international donor money a lot more transparent ... cannot be traced in the budgets of the receiving countries. ...
Cached Medicine News:Health News:Flu Vaccine With Both B Strains May Offer Better Protection 2Health News:Developing countries devote more funding to health, except many in sub-Saharan Africa 2Health News:Developing countries devote more funding to health, except many in sub-Saharan Africa 3Health News:Nicotine Withdrawal Can Complicate Hospital Care 2Health News:Children's National Hosts Fourth Annual Youth Anti-Violence Exhibition 2Health News:Children's National Hosts Fourth Annual Youth Anti-Violence Exhibition 3Health News:Why we need a world social health insurance 2
The Model 273 is a general purpose instrument with output that may be either DC-coupled for very slow changes such as venous occlusion and penile tumescence studies or AC-coupled for respiratory or p...
... Plastic and fabric specialty drapes ... gynecology. Steri-Drape absorbent prevention fabric ... fluid strike-through reducing the need ... Drape Pack, Op tape, Hand ...
... top design takes into account a wide ... flexible working environment for the surgical team. ... be matched exactly to your patients height. ... creates superior access for image amplification procedures. ...
... Mitek is the Market leader in soft ... Suture, DePuy Mitek has developed the latest ... open shoulder repair. ORTHOCORD Suture is as ... the market. Most importantly, ORTHOCORD Suture handles ...
Medicine Products: